In English | En español
Questions About Cancer? 1-800-4-CANCER

Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)

  • Last Modified: 02/14/2014

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document

Changes to This Summary (02/14/2014)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Introduction

Updated statistics with estimated new cases for 2014 (cited American Cancer Society as reference 7).

Multiple Endocrine Neoplasia Type 2

Updated statistics with estimated new cases and deaths for 2014 (cited American Cancer Society as reference 26).

Added text about a retrospective series of 96 patients who underwent surgical resection for hereditary pheochromocytoma that concluded that cortical-sparing surgery is a viable option for patients with hereditary pheochromocytoma, but ongoing surveillance for new or recurrent disease is necessary, especially in those who undergo a laparoscopic procedure (cited Grubbs et al. as reference 222).

This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.